Pancreatic cancer patients needing diagnosis, personalized care, surgery, chemo, radiation or cell therapy
patients and caregivers
physicians seeking surgical training
patients and caregivers
The Da Vinci Minimally Invasive Surgery Center at Chung Shan Medical University Hospital was established in 2015, with pancreatic tumor treatment as a core development direction. Using a "triangular team model," the team integrates multiple treatment options including traditional open surgery, laparoscopic, robotic, single-port minimally invasive, RFA ablation, hyperthermia, and cryotherapy. Cumulative 452 pancreatic cancer surgeries completed, with Da Vinci robotic surgery accounting for 73.4% — the majority. Clinical outcomes: R0 resection rate 63.4% (meeting international standard 50-70%); 30-day post-op mortality <1%; 5-year survival 24.1% (Stage I malignancy reaching 37.7%). For training, it is Taiwan's first manufacturer-certified general surgery Da Vinci observation center (2020) and MIT robotic arm clinical training site, with 595 cumulative trainees and observers from 20 countries including Italy, Germany, Japan, Thailand, and India. The team also collaborates with Feng Chia University on pancreatic VR simulators (4 patents). Awarded 2020 SNQ Certification and 2023 NHQA Excellence Award.
Triangular team model + standardized workflow
Taiwan's first Da Vinci observation center
Multi-modal surgery (robotic/laparoscopic/single-port/open)
Pancreatic VR simulator (4 patents)
Support group + education for holistic care
Trained 595 from 20 countries
Cumulative pancreatic surgeries: 452
Da Vinci robotic surgery: 73.4%
Pancreatic cancer support group: 16 sessions, 867 attendees
Surgical training: 48 trainees from 20 countries
Surgical observation: 547 attendees
Education events: 98 sessions, 2,043 attendees
R0 resection rate: 63.4% (international 50-70%)
30-day post-op mortality: <1%
5-year survival rate: 24.1%
Stage I malignancy 5-year survival: 37.7%
Average hospital stay: 20 days
Single-port to open conversion: 12.3%
Standardized workflow ensures surgical quality
Cross-team resource integration
Dedicated Da Vinci surgery space
Multiple surgical option backup mechanism
Strict pre-op multidisciplinary evaluation
Medical safety indicator monitoring
Overall satisfaction: 4.86 / 5
Medical team professionalism: 4.86 / 5
Post-op follow-up & support group: 4.88 / 5
Hospital environment & nursing: 4.79 / 5
Pre-op education & communication: 4.8 / 5
Education event satisfaction: 4.77 / 5
2020 SNQ National Quality Certification
2023 NHQA Excellence Award
Taiwan's first manufacturer-certified Da Vinci observation center
SCI publications in Surg Endosc and others
595 trainees from 20 countries
4 patents from Feng Chia University collaboration
Establishes benchmark for pancreatic cancer surgery
560 international trainees promote techniques globally
Improves regional hospital pancreatic care capability
Creates VR-based training education model
Support group provides holistic care
